DK0639176T3 - Benzendimethanolderivat, der er egnet til mikronisering - Google Patents
Benzendimethanolderivat, der er egnet til mikroniseringInfo
- Publication number
- DK0639176T3 DK0639176T3 DK92900167.5T DK92900167T DK0639176T3 DK 0639176 T3 DK0639176 T3 DK 0639176T3 DK 92900167 T DK92900167 T DK 92900167T DK 0639176 T3 DK0639176 T3 DK 0639176T3
- Authority
- DK
- Denmark
- Prior art keywords
- salt
- micronization
- benzene dimethanol
- derivative suitable
- hydroxy
- Prior art date
Links
- GCBSCAKBRSMFCP-UHFFFAOYSA-N benzene;methanol Chemical class OC.OC.C1=CC=CC=C1 GCBSCAKBRSMFCP-UHFFFAOYSA-N 0.000 title 1
- UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical class C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 abstract 1
- SWPCURCTHNTSKL-UHFFFAOYSA-N C1=CC=CC2=C(O)C(C(=O)O)=CC=C21.C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 Chemical compound C1=CC=CC2=C(O)C(C(=O)O)=CC=C21.C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 SWPCURCTHNTSKL-UHFFFAOYSA-N 0.000 abstract 1
- 239000002152 aqueous-organic solution Substances 0.000 abstract 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000013081 microcrystal Substances 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 238000010791 quenching Methods 0.000 abstract 1
- 230000000171 quenching effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
- C07C217/10—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polyesters Or Polycarbonates (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909026005A GB9026005D0 (en) | 1990-11-29 | 1990-11-29 | Drug material suitable for micronisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0639176T3 true DK0639176T3 (da) | 1996-12-23 |
Family
ID=10686212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92900167.5T DK0639176T3 (da) | 1990-11-29 | 1991-11-28 | Benzendimethanolderivat, der er egnet til mikronisering |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5380922A (pl) |
| EP (2) | EP0639176B1 (pl) |
| JP (1) | JP3375626B2 (pl) |
| KR (1) | KR100192196B1 (pl) |
| AT (1) | ATE144244T1 (pl) |
| AU (1) | AU644505B2 (pl) |
| BG (1) | BG61340B1 (pl) |
| CA (1) | CA2099586C (pl) |
| CY (1) | CY2009A (pl) |
| CZ (1) | CZ282996B6 (pl) |
| DE (1) | DE69122780T2 (pl) |
| DK (1) | DK0639176T3 (pl) |
| ES (1) | ES2093812T3 (pl) |
| FI (2) | FI118155B (pl) |
| GB (1) | GB9026005D0 (pl) |
| GR (1) | GR3022088T3 (pl) |
| HK (1) | HK78997A (pl) |
| HU (1) | HU218205B (pl) |
| IE (1) | IE914146A1 (pl) |
| OA (2) | OA09861A (pl) |
| PL (2) | PL167976B1 (pl) |
| RU (2) | RU2197475C2 (pl) |
| SG (1) | SG49741A1 (pl) |
| SK (1) | SK281095B6 (pl) |
| TW (1) | TW309425B (pl) |
| WO (1) | WO1992009557A1 (pl) |
| ZA (1) | ZA919401B (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9026005D0 (en) * | 1990-11-29 | 1991-01-16 | Glaxo Group Ltd | Drug material suitable for micronisation |
| AU1229892A (en) * | 1992-02-11 | 1993-09-03 | Glaxo Group Limited | Benzenedimethanol derivative suitable for micronisation |
| US6254882B1 (en) | 1997-09-16 | 2001-07-03 | Sepracor Inc. | Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol |
| PT1169019E (pt) | 1999-04-14 | 2003-07-31 | Glaxo Group Ltd | Formulacao farmaceutica em aerossol |
| EP1328278A4 (en) | 2000-09-26 | 2004-06-16 | Univ Temple | ANALGETIC AND GLUCOSAMINE COMPOSITIONS |
| EP2127641A1 (en) * | 2008-05-26 | 2009-12-02 | Inke, S.A. | Micronisable form of salmeterol xinafoate |
| KR101100614B1 (ko) | 2010-09-20 | 2011-12-29 | 한국수력원자력 주식회사 | 농축폐액 건조물의 펠렛화 장치 및 방법과 이를 이용한 유리조성개발 방법 |
| WO2016142582A1 (en) * | 2015-03-11 | 2016-09-15 | Fermion Oy | Process for the preparation of crystalline salmeterol and its xinafoate salt |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZW6584A1 (en) * | 1983-04-18 | 1985-04-17 | Glaxo Group Ltd | Phenethanolamine derivatives |
| GB9026005D0 (en) * | 1990-11-29 | 1991-01-16 | Glaxo Group Ltd | Drug material suitable for micronisation |
-
1990
- 1990-11-29 GB GB909026005A patent/GB9026005D0/en active Pending
-
1991
- 1991-11-28 ES ES92900167T patent/ES2093812T3/es not_active Expired - Lifetime
- 1991-11-28 CA CA002099586A patent/CA2099586C/en not_active Expired - Lifetime
- 1991-11-28 CZ CS931019A patent/CZ282996B6/cs not_active IP Right Cessation
- 1991-11-28 RU RU97121416/04A patent/RU2197475C2/ru active
- 1991-11-28 DK DK92900167.5T patent/DK0639176T3/da active
- 1991-11-28 RU RU93040704A patent/RU2116293C1/ru active
- 1991-11-28 IE IE414691A patent/IE914146A1/en not_active IP Right Cessation
- 1991-11-28 HU HU9301568A patent/HU218205B/hu unknown
- 1991-11-28 SK SK545-93A patent/SK281095B6/sk not_active IP Right Cessation
- 1991-11-28 PL PL91299352A patent/PL167976B1/pl unknown
- 1991-11-28 SG SG1996004594A patent/SG49741A1/en unknown
- 1991-11-28 ZA ZA919401A patent/ZA919401B/xx unknown
- 1991-11-28 WO PCT/GB1991/002108 patent/WO1992009557A1/en not_active Ceased
- 1991-11-28 DE DE69122780T patent/DE69122780T2/de not_active Expired - Lifetime
- 1991-11-28 EP EP92900167A patent/EP0639176B1/en not_active Expired - Lifetime
- 1991-11-28 JP JP50047092A patent/JP3375626B2/ja not_active Expired - Lifetime
- 1991-11-28 PL PL91308211A patent/PL169722B1/pl unknown
- 1991-11-28 AU AU90402/91A patent/AU644505B2/en not_active Ceased
- 1991-11-28 AT AT92900167T patent/ATE144244T1/de not_active IP Right Cessation
-
1992
- 1992-05-21 EP EP92304635A patent/EP0571669B1/en not_active Expired - Lifetime
- 1992-05-29 TW TW081104199A patent/TW309425B/zh active
-
1993
- 1993-05-14 US US08/050,298 patent/US5380922A/en not_active Expired - Lifetime
- 1993-05-14 OA OA60370A patent/OA09861A/en unknown
- 1993-05-25 BG BG97767A patent/BG61340B1/bg unknown
- 1993-05-27 FI FI932422A patent/FI118155B/fi not_active IP Right Cessation
- 1993-05-27 KR KR1019930701589A patent/KR100192196B1/ko not_active Expired - Lifetime
- 1993-09-24 OA OA60416A patent/OA10024A/en unknown
-
1996
- 1996-12-18 GR GR960403534T patent/GR3022088T3/el unknown
-
1997
- 1997-06-12 HK HK78997A patent/HK78997A/en not_active IP Right Cessation
-
1998
- 1998-02-20 CY CY200998A patent/CY2009A/xx unknown
- 1998-09-28 FI FI982081A patent/FI118203B/fi not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0639176T3 (da) | Benzendimethanolderivat, der er egnet til mikronisering | |
| GB9309324D0 (en) | Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives | |
| FI894718A0 (fi) | Pigmentationssupplement foer djurfoderkompositioner. | |
| ES2061179T3 (es) | Preparaciones granuladas y metodo para producirlas. | |
| FR2656526B1 (fr) | Dispositif a liberation controlee et procede de preparation. | |
| GR3018293T3 (en) | N-(N-(tetrahydropyrido(2,3-d)pyrimidinylmethyl)-aminomethylbenzoyl)glutamic acid derivatives. | |
| RU93040704A (ru) | 1-гидрокси-2-нафталинкарбоксилатная соль 4-гидрокси-альфа-[[[6-(4-фенилбутокси)гексил]амино]метил]-1,3-бензолдиметанола в форме сферических сращений микрокристаллов, способ ее измельчения, способ ее получения, применение гидроксинафтоата для получения измельченной гидроксинафтоатной соли | |
| JPS6413004A (en) | Sustained release ferrous sulfate | |
| DK0590382T3 (da) | Fremgangsmåde til fremstilling af pellets af et efedrinderivat | |
| MY108410A (en) | Drug material suitable for micronisation. | |
| GR3005944T3 (pl) | ||
| Verkhovskii et al. | Structure and Properties of Steels After Quenching in Magnetic Liquid | |
| CA2003494A1 (en) | Fabric treatment composition | |
| Nakae | The Role of Solidification in Developing Materials | |
| Gorynya et al. | Development of phase transition in the condenser photo-emf of CdP sub (2). | |
| Marinskii et al. | Examination of the Effect of Working Parameters on the Temperature and Energy Parameters of Electroslag Crucible Melting | |
| YU56692A (sh) | Novi, za mikronizaciju pogodan oblik 1-hidrok-si-2-naftalin-karboksilatne soli 4-hidroksi-alfa1-///6-(4-fenilbutoksi)-hebsil/amino/metil/-1,3 benzoldimetanola i postupak za njegovo dobijanje | |
| NO862907L (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat med forsinket virkestoff - frigjoering. | |
| KOLOMEEV et al. | Climatic consequences of the movement of smoke to the stratosphere(Klimaticheskie posledstviia vynosa dyma v stratosferu) | |
| JPS5528926A (en) | Preparation of 5-fluoro-uridine | |
| JPS5639783A (en) | Fixed protease and its preparation | |
| Jurci et al. | Microstructural Development and Phase Transformations in Fe-4 C-12 Cr-13 V RS Powder during Annealing | |
| Golub et al. | Temperature Dependence of the Titanium Carbide Young Modulus and Eutectic Chromium--Titanium Carbide Alloys | |
| Zenker | Heat Treatment by Electron Beam | |
| JPS5424845A (en) | Novel bio-active peptide and its derivative |